Status:
COMPLETED
GlucoVIP - Diabetes Treatment by Glucobay® With a Special Therapeutic View to Chosen Patient Groups
Lead Sponsor:
Bayer
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Brief Summary
Evaluation of safety and effectiveness of Glucobay® under daily-life treatment conditions in a large sample of patients.
Eligibility Criteria
Inclusion
- Patients with untreated or pretreated diabetes mellitus or patients for which acarbose is indicated and without acarbose treatment within the last three months before study inclusion. The decision for treatment type and duration is taken by the investigator and is made before inclusion into the study.
Exclusion
- Exclusion criteria must be read in conjunction with the local product information.
Key Trial Info
Start Date :
March 24 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2010
Estimated Enrollment :
15729 Patients enrolled
Trial Details
Trial ID
NCT00909051
Start Date
March 24 2009
End Date
December 31 2010
Last Update
June 6 2023
Active Locations (16)
Enter a location and click search to find clinical trials sorted by distance.
1
Multiple Locations, Algeria
2
Multiple Locations, Bosnia and Herzegovina
3
Multiple Locations, Cambodia
4
Multiple Locations, China